| Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. I Vlodavsky, J Folkman, R Sullivan, R Fridman, R Ishai-Michaeli, J Sasse, ... Proceedings of the National Academy of Sciences 84 (8), 2292-2296, 1987 | 1347 | 1987 |
| Matrix metalloproteinases: structures, evolution, and diversification I Massova, LP Kotra, R Fridman, S Mobashery The FASEB Journal 12 (12), 1075-1095, 1998 | 1215 | 1998 |
| A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia Z Gu, J Cui, S Brown, R Fridman, S Mobashery, AY Strongin, SA Lipton Journal of Neuroscience 25 (27), 6401-6408, 2005 | 563 | 2005 |
| Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer B Schmalfeldt, D Prechtel, K Härting, K Späthe, S Rutke, E Konik, ... Clinical Cancer Research 7 (8), 2396-2404, 2001 | 497 | 2001 |
| Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1. E Levi, R Fridman, HQ Miao, YS Ma, A Yayon, I Vlodavsky Proceedings of the National Academy of Sciences 93 (14), 7069-7074, 1996 | 475 | 1996 |
| Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2) R Fridman, M Toth, D Peña, S Mobashery Cancer research 55 (12), 2548-2555, 1995 | 452 | 1995 |
| Discoidin domain receptor tyrosine kinases: new players in cancer progression RR Valiathan, M Marco, B Leitinger, CG Kleer, R Fridman Cancer and Metastasis Reviews 31, 295-321, 2012 | 422 | 2012 |
| Identification of CD63 as a tissue inhibitor of metalloproteinase‐1 interacting cell surface protein KK Jung, XW Liu, R Chirco, R Fridman, HRC Kim The EMBO journal 25 (17), 3934-3942, 2006 | 396 | 2006 |
| Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 … S Hernandez-Barrantes, M Toth, MM Bernardo, M Yurkova, DC Gervasi, ... Journal of Biological Chemistry 275 (16), 12080-12089, 2000 | 390 | 2000 |
| Kinetic analysis of the binding of human matrix metalloproteinase-2 and-9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 MW Olson, DC Gervasi, S Mobashery, R Fridman Journal of Biological Chemistry 272 (47), 29975-29983, 1997 | 374 | 1997 |
| Type IV collagenase (s) and TIMPs modulate endothelial cell morphogenesis in vitro HW Schnaper, DS Grant, WG Stetler‐Stevenson, R Fridman, G D'Orazi, ... Journal of cellular physiology 156 (2), 235-246, 1993 | 365 | 1993 |
| Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and-9 J Ochieng, R Fridman, P Nangia-Makker, DE Kleiner, LA Liotta, ... Biochemistry 33 (47), 14109-14114, 1994 | 354 | 1994 |
| Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells G Li, R Fridman, HRC Kim Cancer research 59 (24), 6267-6275, 1999 | 335 | 1999 |
| Assessment of gelatinases (MMP-2 and MMP-9) by gelatin zymography M Toth, A Sohail, R Fridman Metastasis research protocols, 121-135, 2012 | 329 | 2012 |
| Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines. R Fridman, G Giaccone, T Kanemoto, GR Martin, AF Gazdar, JL Mulshine Proceedings of the National Academy of Sciences 87 (17), 6698-6702, 1990 | 317 | 1990 |
| High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer DJ Grignon, W Sakr, M Toth, V Ravery, J Angulo, F Shamsa, JE Pontes, ... Cancer Research 56 (7), 1654-1659, 1996 | 307 | 1996 |
| Assessment of gelatinases (MMP-2 and MMP-9 by gelatin zymography M Toth, R Fridman Metastasis Research Protocols: Volume I: Analysis of Cells and Tissues, 163-174, 2001 | 294 | 2001 |
| Epidermal growth factor and amphiregulin up‐regulate matrix metalloproteinase‐9 (MMP‐9) in human breast cancer cells SB Kondapaka, R Fridman, KB Reddy International journal of cancer 70 (6), 722-726, 1997 | 292 | 1997 |
| Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 … R Fridman, TR Fuerst, RE Bird, M Hoyhtya, M Oelkuct, S Kraus, ... Journal of Biological Chemistry 267 (22), 15398-15405, 1992 | 276 | 1992 |
| Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis JA Nemeth, R Yousif, M Herzog, M Che, J Upadhyay, B Shekarriz, ... Journal of the National Cancer Institute 94 (1), 17-25, 2002 | 275 | 2002 |
